Skip to main content

ScienceDex / Researcher record

Norman, Andrew B

From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.

FY2021 NIH rank #1,832
  • Sustained Excellence
  • Program Leader
  • Long-Funded
  • Top 10% Funded

NIH Funding · FY2021

$2.9M
Full award amounts, FY2021
2
Records listing this PI
#1,832
By linked amount among FY2021 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$444,2991#13,872
2007$911,1201#7,327
2008$922,7211#6,885
2009$133,6841#37,574
2010$785,0001#10,809
2011$761,4501#9,533
2012$761,4501#9,570
2013$730,9921#9,470
2014$761,4501#9,443
2015$2,108,0091#2,600
2016$2,065,1591#2,614
2017$2,086,0191#2,488
2019$6,567,0182#401
2020$1,925,8271#982
2021$2,886,8952#1,832

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20061 record
  2. FY20071 record
  3. FY20081 record
  4. FY20091 record
  5. FY20101 record
  6. FY20111 record
  7. FY20121 record
  8. FY20131 record
  9. FY20141 record
  10. FY20151 record
  11. FY20161 record
  12. FY20171 record
  13. FY20192 records
  14. FY20201 record
  15. FY2021 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Norman, Andrew B. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2021 award categories

  • Pharmacology

FY2021 award records by amount

NIH award records listing Norman, Andrew B as a PI. Multi-PI records show the full award amount for context.

  • 5U01DA048525-03U01Contact PI
    First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody
    University of Cincinnati · Pharmacology (NIH department code)
    $1.8M
    award amount
  • 5U01DA050330-03U01Contact PI
    IND-Enabling Pre-Clinical Studies to Accelerate the Clinical Development of a Humanized Anti-Cocaine Monoclonal Antibody
    University of Cincinnati · Pharmacology (NIH department code)
    $1.1M
    award amount

Award organization

Organizations that administered FY2021 awards listing Norman, Andrew B as a PI.

FY2021 award administered by University of Cincinnati (OH).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    University of Cincinnati
  2. 2007
    $500K Cumulative Funding
  3. 2007
    $1M Cumulative Funding
  4. 2007
    Entered Top 50% Nationally
    Ranked #7327
  5. 2008
    $2M Cumulative Funding
  6. 2013
    $5M Cumulative Funding
  7. 2013
    Program/Center Grant Leader
  8. 2015
    Entered Top 25% Nationally
    Ranked #2600
  9. 2016
    $10M Cumulative Funding
  10. 2019
    Entered Top 10% Nationally
    Ranked #401
  11. 2019
    Entered Top 5% Nationally
    Ranked #401